Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Boehringer Ingelheim
Cerilliant
Accenture
Julphar
Harvard Business School
Citi
UBS
Moodys

Generated: April 27, 2018

DrugPatentWatch Database Preview

HALDRONE Drug Profile

« Back to Dashboard

When do Haldrone patents expire, and when can generic versions of Haldrone launch?

Haldrone is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in HALDRONE is paramethasone acetate. There are two drug master file entries for this compound. Additional details are available on the paramethasone acetate profile page.
Drug patent expirations by year for HALDRONE
Medical Subject Heading (MeSH) Categories for HALDRONE
Synonyms for HALDRONE
(6alpha,11beta,16alpha)-6-fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl acetate
[2-[(6s,8s,9s,10r,11s,13s,14s,16r,17r)-6-fluoro-11,17-dihydr
[2-[(6S,8S,9S,10R,11S,13S,14S,16R,17R)-6-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
1597-82-6
16-alpha-Methyl-6-alpha-fluoro-prednisolone-21-acetate
2-[(1S,2R,8S,10S,11S,13R,14R,15S,17S)-8-FLUORO-14,17-DIHYDROXY-2,13,15-TRIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-14-YL]-2-OXOETHYL ACETATE
21-Acetyl-6-alpha-fluoro-16-alpha-methylprednisolone
25466-29-9
6-alpha-Fluoro-16-alpha-methylprednisolone 21-acetate
6alpha-Fluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 21-acetate
6alpha-fluoro-11beta,17alpha,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione acetate
8X50N88ZDP
AC1L9FF9
Acetate de paramethasone
AJ-48961
C12656
CAS-1597-82-6
CHEBI:31963
CHEMBL1200342
Cortidene
D01229
Dilar
DSSTox_CID_3422
DSSTox_GSID_23422
DSSTox_RID_77021
DTXSID8023422
EINECS 216-486-4
Haldrate
Haldrone (TN)
LMST02030123
Monocortin
NCGC00185748-01
Paramethasone 21-acetate
PARAMETHASONE ACETATE
Paramethasone acetate (JAN/USP)
Paramethasone acetate [USAN:JAN]
Paramethazone acetate
PL008802
Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-6-fluoro-11,17-dihydroxy-16-methyl-, (6alpha,11beta,16alpha)-
Pregna-1,4-diene-3,20-dione, 6-alpha-fluoro-11-beta,17,21-trihydroxy-16-alpha-methyl-, 21-acetate
SCHEMBL7126
Sintecort
Stemex
Tox21_113132
UNII-8X50N88ZDP
ZINC4214095

US Patents and Regulatory Information for HALDRONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly HALDRONE paramethasone acetate TABLET;ORAL 012772-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly HALDRONE paramethasone acetate TABLET;ORAL 012772-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for HALDRONE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lilly HALDRONE paramethasone acetate TABLET;ORAL 012772-005 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Lilly HALDRONE paramethasone acetate TABLET;ORAL 012772-006 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
US Department of Justice
Medtronic
McKesson
Cerilliant
Federal Trade Commission
Teva
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.